Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | TAR-binding protein | 0.0074 | 0.0189 | 0.0189 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.0189 | 0.0189 |
Brugia malayi | RNA binding protein | 0.0074 | 0.0189 | 0.0189 |
Echinococcus multilocularis | MAP kinase activated protein kinase 2 | 0.1144 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0074 | 0.0189 | 0.0189 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0074 | 0.0189 | 0.0189 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0058 | 0.0044 | 0.0044 |
Echinococcus granulosus | MAP kinase activated protein kinase 2 | 0.1144 | 1 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0058 | 0.0044 | 0.0044 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | hypothetical protein | 0.0237 | 0.1687 | 0.1687 |
Loa Loa (eye worm) | TAR-binding protein | 0.0074 | 0.0189 | 0.0189 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.0189 | 0.0189 |
Echinococcus multilocularis | tar DNA binding protein | 0.0074 | 0.0189 | 0.0189 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | RNA binding protein | 0.0074 | 0.0189 | 0.0189 |
Schistosoma mansoni | tar DNA-binding protein | 0.0074 | 0.0189 | 0.0189 |
Loa Loa (eye worm) | camk/mapkapk/mapkapk protein kinase | 0.1144 | 1 | 1 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0198 | 0.1322 | 0.1322 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0237 | 0.1687 | 0.1687 |
Echinococcus granulosus | tar DNA binding protein | 0.0074 | 0.0189 | 0.0189 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0198 | 0.1322 | 0.1322 |
Schistosoma mansoni | serine/threonine protein kinase | 0.1144 | 1 | 1 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.